The DREAM Challenge is an open innovation non-profit biology project in which scientists share ideas and data. AstraZeneca’s move is aimed at advancing research into combination cancer therapy
The new biotechnology, dubbed the Cybercyte, is designed to cut in half the time and money required for preclinical trials. Cytocybernetics claims that the new technology could rapidly
The company will use the grant to discover preclinical DUB inhibitors directed at specific deubiquitylating enzymes (DUBs), which are involved in several cellular processes, including DNA damage and
The test uses real-time PCR technology for identifying and separating influenza A virus and influenza B virus RNA in 20 minutes. Highly conserved regions of the influenza A
The companies will start a managed access program in selected countries for NP001, Neuraltus’ investigational therapy for ALS. Coverage is planned to be expanded in the next year.
Merck carried out the MODIFY I study in 19 countries participated by more than 1,400 patients with a median age of 65. MODIFY II study had over 1,200
Intuniv, a drug for the treatment of ADHD in children and adolescents from 6 to 17 years old, is already licensed in the US and Canada. Shire said
Last year, Sun Pharma acquired Ranbaxy Laboratories in an all-stock transaction totalling equity value of $3.2bn. However, earlier this year Sun Pharma said as a part of the
The FDA will review Kyprolis in combination with dexamethasone for patients with relapsed multiple myeloma following prior treatment with at least one therapy, based on findings from the
The transaction is expected to be completed in the first half of 2016. It includes United Drug and United Drug Sangers, wholesale operations across the Republic of Ireland
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.